Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.61 HKD
Change Today +0.07 / 12.96%
Volume 185.0K
401 On Other Exchanges
Hong Kong
As of 4:01 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

wanjia group holdings ltd (401) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/16/15 - $2.38
52 Week Low
12/8/14 - $0.39
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for WANJIA GROUP HOLDINGS LTD (401)

Related News

No related news articles were found.

wanjia group holdings ltd (401) Related Businessweek News

No Related Businessweek News Found

wanjia group holdings ltd (401) Details

Wanjia Group Holdings Limited, an investment holding company, wholesales and distributes pharmaceutical products in the People’s Republic of China. It operates through two divisions, Pharmaceutical Wholesale and Distribution Business; and Pharmaceutical Retail Chain Business. The company sells its pharmaceutical products to public hospitals and healthcare institutions; distributor customers; and end customers, such as companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in the Fujian, Guangdong, Hunan, Hubei, Jiangxi, Aunhui, and Zhejiang provinces. Its retail pharmacies offer prescription medicines, over-the-counter medicines, healthcare food products, traditional Chinese medicines, medical supplies, and medical devices. As of March 31, 2015, the company had 119 retail pharmacies in Fujian Province under the Huihao Sihai brand name. The company was founded in 2004 and is headquartered in Hong Kong, Hong Kong. Wanjia Group Holdings Limited is a subsidiary of Greatly Wealth Global Group Limited.

1,046 Employees
Last Reported Date: 06/30/15
Founded in 2004

wanjia group holdings ltd (401) Top Compensated Officers

Executive Director
Total Annual Compensation: $28.0K
Executive Director
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

wanjia group holdings ltd (401) Key Developments

Wanjia Group Holdings Limited Announces Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2015

Wanjia Group Holdings Limited announced unaudited consolidated earnings results for the first quarter ended June 30, 2015. For the quarter, the company reported turnover of HKD 312,167,000 against HKD 398,546,000 a year ago. Profit from operations was HKD 653,000 against loss from operations of KHD 769,610,000 a year ago. Loss before taxation was HKD 2,487,000 against HKD 771,484,000 a year ago. Loss for the period attributable to owners of the company was HKD 3,671,000 or 0.57 cents per basic and diluted share against HKD 774,920,000 or 119.51 cents per basic and diluted share a year ago. The decrease in turnover was mainly attributable to decrease in revenue generated from the pharmaceutical wholesales segment as a result of the promulgation and implementation of new Good Supply Practice in Fujian, the People's Republic of China in April 2014 which imposes stringent regulations on pharmaceutical distributor operation.

Wanjia Group Holdings Limited Appoints Yung Ka Lai as Executive Director

The board of directors of Wanjia Group Holdings Limited announced that Ms. Yung Ka Lai has been appointed as the executive Director with effective from 5 August 2015.

Wanjia Group Holdings Limited to Report Q1, 2016 Results on Aug 14, 2015

Wanjia Group Holdings Limited announced that they will report Q1, 2016 results on Aug 14, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
401:HK $0.61 HKD +0.07

401 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Nepstar Chain Drugstore Ltd $2.18 USD 0.00
Huadong Medicine Co Ltd CNY76.44 CNY +3.64
Jointown Pharmaceutical Group Co Ltd CNY17.59 CNY +1.34
Nanjing Pharmaceutical Co Ltd CNY8.99 CNY +0.78
Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd CNY49.99 CNY +2.19
View Industry Companies

Industry Analysis


Industry Average

Valuation 401 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WANJIA GROUP HOLDINGS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at